SS
QTTB icon

SBI Securities’s Q32 Bio QTTB Stock Holding History

SBI Securities’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$668 Sell
104
-53
-34% -$252 ﹤0.01% 2792
2025
Q4 		$521 Sell
157
-7,999
-98% -$22.6K ﹤0.01% 2862
2025
Q3 		$16.1K Buy
8,156
+1
+0% +$2 ﹤0.01% 1542
2025
Q2 		$12.2K Buy
8,155
+8,008
+5,448% +$13.7K ﹤0.01% 1620
2025
Q1 		$243 Sell
147
-91
-38% -$245 ﹤0.01% 3150
2024
Q4 		$819 Buy
+238
New +$7.51K ﹤0.01% 2698

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SBI Securities's QTTB Position: Q1 2026 in Review

SBI Securities reduced its Q32 Bio (QTTB) stake by 34% in Q1 2026, selling an estimated $252 and leaving 104 shares worth $668. The position accounts for ﹤0.01% of the portfolio, ranked #2792.

SBI Securities first reported a position in QTTB in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.1K in Q3 2025. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • SBI Securities held 104 shares of Q32 Bio worth $668 as of Q1 2026.
  • SBI Securities sold 53 Q32 Bio shares in Q1 2026, an estimated $252.
  • Q32 Bio made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2792 holding.
  • SBI Securities first reported a position in Q32 Bio in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Q32 Bio position peaked at $16.1K in Q3 2025.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.